Navigation Links
Fat Reduction Market in Europe to Soar Despite Economic Downturn
Date:7/16/2009

WALTHAM, Mass., July 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the fat reduction device market will experience the highest growth of all body contouring devices in Europe through 2013. MRG's European Markets for Body Contouring Devices 2009 report finds that the fat reduction segment will be fueled by physician adoption of newer modalities like transdermal ultrasound and laser, light, and energy fat reduction devices, which offer patients less invasive solutions than traditional liposuction.

Transdermal ultrasound and laser-assisted liposuction (LAL) procedures will experience particularly strong growth over the next five years, with patient desire for minimally invasive procedures fueling both segments. Transdermal ultrasound procedures can be performed in an hour and without any incisions, allowing patients to return to their normal routine afterwards. Until recently, the market for transdermal ultrasound was dominated by UltraShape; however, the competitive landscape has changed with the launch of Medicis' LipoSonix in mid-2008, and it will continue to shift over the next five years as new firms enter the market in an attempt to capitalize on the rapid growth.

"The LAL market is undergoing similar competitive changes. As LAL continues to stimulate patient demand, physicians will purchase new LAL devices and new competitors will emerge in order to capitalize on the market's tremendous potential," says Kevin Flewwelling, Manager of the Aesthetics division at MRG. "DEKA's SmartLipo device was one of the first LAL devices available in the European market; however, many competitors have since launched LAL devices, including Cynosure, Eleme Medical, Sciton, Syneron, and others."

MRG's European Markets for Body Contouring Devices 2009 report covers the markets for cellulite reduction, skin tightening, fat reduction, and gastric bands in France, Germany, Italy, Spain, and the UK. The report provides full breakdowns of body contouring procedures by type as well as device unit sales by subtype, including five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages
2. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
3. Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate
4. Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing
5. Studies Show Groundbreaking 22% Reduction in Depression Symptoms in 4 Hours
6. Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers
7. Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
8. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
9. New study finds Power Plate exercise aids in weight loss, reduction of harmful visceral fat
10. New Study Finds Power Plate(R) Exercise Aids in Weight Loss, Reduction of Harmful Visceral Fat
11. Massive decline in rates of coronary death in Iceland are largely attributed to risk factor reductions in the population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held last ... Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred ... Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served APDA ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... On June 9-10, Las Vegas will host ... (CME) event presented by the Association for Comprehensive Care in Rare Diseases (ACCORD). ... mission is to provide education, tools, and resources to primary care clinicians that ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Global Immunology ... market to drive long-term market growth Summary ... set of chronic disorders that affect 5–7% of ... terms of their symptoms and key patient demographics, ... of immune pathways and an inappropriate immune response. ...
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
Breaking Medicine Technology: